biotech stocks Archives - Cabot Wealth Network
  • Home
  • Daily
    • Dividend Stocks
    • Emerging Markets
    • ETFs
    • Growth Stocks
    • How To Invest
    • Income Investing
    • Options Trading
    • Personal Finance
    • Precious Metals Investing
    • Real Estate Investing
    • Small-Cap Stocks
    • Stock Market
    • Value Investing
  • Free Resources
    • Daily
    • Free Reports
    • Previews
    • Videos
    • Webinars
  • Advisories
    • Growth
      • Cabot Growth Investor
      • Cabot Top Ten Trader
      • Cabot Small-Cap Confidential
      • Cabot Early Opportunities
    • Income
      • Cabot Dividend Investor
      • Cabot Income Advisor
    • Options
      • Cabot Options Trader
      • Cabot Options Trader Pro
      • Cabot Profit Booster
      • Cabot Options Institute Quant Trader
      • Cabot Options Institute Income Trader
      • Cabot Options Institute Fundamentals
      • Cabot Options Institute Earnings Trader
    • Diversified
      • Cabot Stock of the Week
      • Cabot Explorer
    • Value
      • Cabot Micro-Cap Insider
      • Cabot Turnaround Letter
      • Cabot Undervalued Stocks Advisor
    • Sector
      • Cabot SX Cannabis Advisor
      • Cabot SX Crypto Advisor
      • Cabot SX Greentech Advisor
      • Cabot SX Gold & Metals Advisor
  • Memberships
    • Cabot Prime Pro
    • Cabot Prime Plus
    • Cabot Options Institute Masters Club
    • Cabot Retirement Club
    • Cabot Sector Xpress Club
    • Cabot Money Club
  • Institute
    • Cabot Options Institute Masters Club
    • Cabot Options Institute Quant Trader
    • Cabot Options Institute Income Trader
    • Cabot Options Institute Fundamentals
    • Cabot Options Institute Earnings Trader
    • Cabot Options Institute Daily News – Free
  • Events
    • Summit
    • Webinars
  • About
  • Manage Account
  • Contact Us
  • Privacy Policy, Terms of Use, and Premium Service User Agreement
  • Analyst Index
  • Glossary
  • Keyword Index
  • Browse Topics
  • Daily Archive

Cabot Wealth Network Logo

  • Home
  • Daily
    • Dividend Stocks
    • Emerging Markets
    • ETFs
    • Growth Stocks
    • How To Invest
    • Income Investing
    • Options Trading
    • Personal Finance
    • Precious Metals Investing
    • Real Estate Investing
    • Small-Cap Stocks
    • Stock Market
    • Value Investing
  • Free Resources
    • Daily
    • Free Reports
    • Previews
    • Videos
    • Webinars
  • Advisories
    • Growth
      • Cabot Growth Investor
      • Cabot Top Ten Trader
      • Cabot Small-Cap Confidential
      • Cabot Early Opportunities
    • Income
      • Cabot Dividend Investor
      • Cabot Income Advisor
    • Options
      • Cabot Options Trader
      • Cabot Options Trader Pro
      • Cabot Profit Booster
      • Cabot Options Institute Quant Trader
      • Cabot Options Institute Income Trader
      • Cabot Options Institute Fundamentals
      • Cabot Options Institute Earnings Trader
    • Diversified
      • Cabot Stock of the Week
      • Cabot Explorer
    • Value
      • Cabot Micro-Cap Insider
      • Cabot Turnaround Letter
      • Cabot Undervalued Stocks Advisor
    • Sector
      • Cabot SX Cannabis Advisor
      • Cabot SX Crypto Advisor
      • Cabot SX Greentech Advisor
      • Cabot SX Gold & Metals Advisor
  • Memberships
    • Cabot Prime Pro
    • Cabot Prime Plus
    • Cabot Options Institute Masters Club
    • Cabot Retirement Club
    • Cabot Sector Xpress Club
    • Cabot Money Club
  • Institute
    • Cabot Options Institute Masters Club
    • Cabot Options Institute Quant Trader
    • Cabot Options Institute Income Trader
    • Cabot Options Institute Fundamentals
    • Cabot Options Institute Earnings Trader
    • Cabot Options Institute Daily News – Free
  • Events
    • Summit
    • Webinars
  • About
  • Sign In
  • Register
  • | Register

What are Negative Enterprise Value Stocks? They’re Rare, but Very Profitable

biotech stocks Archives

What are Negative Enterprise Value Stocks? They’re Rare, but Very Profitable

What are Negative Enterprise Value Stocks? They’re Rare, but Very Profitable

July 26, 2022|by Rich Howe

Negative enterprise value stocks are hard to find. But having outperformed the market by more than 5-to-1, they're worth hunting for.
Read More

The Best Protein and DNA Stocks to Play the Sequencing Trend

The Best Protein and DNA Stocks to Play the Sequencing Trend

June 6, 2022|by Tyler Laundon

Cutting-edge work is being done in protein engineering, protein sequencing and protein-analysis. Here are the best protein and DNA stocks to play the protein trend.
Read More

5 Power Fintech ETFs to Buy for 2022

5 Power Fintech ETFs to Buy for 2022

June 2, 2022|by Carl Delfeld

The rise of financial technology has been a positive theme of late. With that in mind, these five fintech ETFs are worth your consideration.
Read More

Ultragenyx Stock: The RARE Growth Title Acting Well Right Now

Ultragenyx Stock: The RARE Growth Title Acting Well Right Now

November 13, 2020|by Mike Cintolo

Growth stocks have fallen flat in recent weeks. But there are encouraging signs of a turnaround, and Ultragenyx stock has already broken out.
Read More

3 Resilient Stocks that are Zigging While the Market Zags

3 Resilient Stocks that are Zigging While the Market Zags

September 15, 2020|by Bruce Kaser

While the rest of the market retreats, these three resilient stocks have been trending up. Here's why they might just be getting started.
Read More

3 Small-Cap Biotech Stocks that Could Cure Coronavirus

3 Small-Cap Biotech Stocks that Could Cure Coronavirus

March 25, 2020|by Nancy Zambell

Biotechs around the world are scrambling to find a coronavirus vaccine. These three small-cap biotech stocks appear to be among the closest.
Read More

Investing Implications for the Best-, Base- and Worst-Case Coronavirus Scenarios

Investing Implications for the Best-, Base- and Worst-Case Coronavirus Scenarios

March 19, 2020|by Tyler Laundon

What are the investing implications of a best-, base- and worst-case scenario for Americans amid this global pandemic? Let's break it down.
Read More

The 10 Best-Performing Micro-Cap Stocks of 2019

The 10 Best-Performing Micro-Cap Stocks of 2019

January 8, 2020|by Tyler Laundon

The best-performing micro-cap stocks of 2019 can give us some insight as to what stocks (and sectors) will be the big small-company winners in 2020.
Read More

MedTech Stocks: The One Growth Market You Can’t Ignore

MedTech Stocks: The One Growth Market You Can’t Ignore

February 21, 2019|by Tyler Laundon

MedTech Stocks: Stable, Yet Defensive Growth Medical technology, or MedTech, stocks, have long been a favorite for growth investors due to the attractive qualities of gradual, long-term growth in a relatively defensive industry. Throw in M&A potential and it’s not hard to see why group...
Read More

Daily Alert – 2/11/19

February 11, 2019|by Richard Moroney, CFA

This biotech is somewhat speculative, but analysts expect it to grow by 22% annually for the next five years.
Read More

3 Small-Cap Sectors Poised for Big Growth in 2018

January 24, 2018|by Tyler Laundon

While small caps as a group lagged behind the broad market in 2017, these three small-cap sectors have plenty of momentum and are poised for more in 2018.
Read More

Is Buying Biotech Stocks a Good Idea?

Is Buying Biotech Stocks a Good Idea?

December 12, 2017|by Chris Preston

Buying biotech stocks seems like a contrarian play at the moment. But it made one day trader a lot of money. Here's what it says about the current market.
Read More

The 5 Best Small-Cap Biotech IPOs of 2017

The 5 Best Small-Cap Biotech IPOs of 2017

September 20, 2017|by Tyler Laundon

In a busy year for IPOs, small cap biotech IPOs have been popping up everywhere. Here are five of them that I really like.
Read More

How the Gilead-Kite Pharma Deal Is Driving Biotech Stocks

How the Gilead-Kite Pharma Deal Is Driving Biotech Stocks

September 1, 2017|by Chris Preston

After two months of churn, biotech stocks are suddenly red-hot thanks to a blockbuster Gilead-Kite Pharma deal that's propping up the entire sector.
Read More

Why TEVA Stock Fell 40% in Three Days

August 9, 2017|by Chris Preston

Most biotechs have been red-hot, but Teva Pharmaceuticals (TEVA) just fell 40% in three days. Here's what happened to TEVA stock.
Read More

3 Soaring Small-Cap Healthcare Stocks to Buy Now

3 Soaring Small-Cap Healthcare Stocks to Buy Now

July 26, 2017|by Tyler Laundon

Small-cap healthcare stocks have been the best performing sector this year, and these three stocks stand above the crowd.
Read More

Where to Find the Best Biotech Stocks

June 30, 2017|by Mike Cintolo

The biotech sector is in full recovery mode, and the best biotech stocks are still on sale. Here's where you can find them.
Read More

How to Play Biotech Stocks After Record Breakout

June 27, 2017|by Chris Preston

Biotech stocks shot up 9.5% last week, and some stocks much more than that. That makes the sector a great place for short-term momentum plays.
Read More

Should You Invest in this Biotech Stock Before It Goes Public?

Should You Invest in this Biotech Stock Before It Goes Public?

May 11, 2017|by Tyler Laundon

There's an intriguing private medical device maker that may soon come public on the NYSE. Here's how you can invest in this biotech stock before its IPO.
Read More

Growth Stocks Poised for Banner 2017

Growth Stocks Poised for Banner 2017

December 29, 2016|by Mike Cintolo

Most growth stocks missed the late-2016 rally, and many have been stuck in neutral for nearly three years. Expect that to change in a big way next year.
Read More

Older Articles

What Can We Help You With?

What Can We Help You With?

As Seen On

As seen on these popular channels

Our Newsletter Updates

Browse Topics

  • Dividend Stocks
  • Emerging Markets
  • ETFs
  • Growth Stocks
  • How To Invest
  • Income Investing
  • Options Trading
  • Personal Finance
  • Precious Metals Investing
  • Real Estate Investing
  • Small-Cap Stocks
  • Stock Market
  • Value Investing

Recent Previews

  • How to Prevent Inflation from Draining Your Wallet!
  • How to Invest During these Inflationary Times—and with a Volatile Market, too!
  • How to Avoid the Biggest Investing Schemes and Rip-Offs!

Latest Videos

Video: Market’s Continued Baby Steps | Cabot Weekly Review

Upcoming Events

Growth & Income-Producing Stocks for an Inflationary Environment

FREE WEBINAR: August 18, 2022 at 2:00 PM ET with Nancy Zambell , Chief Analyst, Cabot Money Club

Space is limited so sign up now for FREE.

Free Reports

  • Essential Guide to High-Probability Trading
  • The 7 Best Places in the World to Retire on a Budget
  • How to Invest in Precious Metals: More Than Just Buying the Best Gold Stock
  • 5 Best Stocks to Buy in August
  • Cabot’s Best Dividend Stocks
  • How Options Work—and How to Hedge Portfolios with Options
  • How to Find Undervalued Stocks
  • How to Invest in Stocks and Other Investing Basics
  • Mortgage Interest Rates: How to Find the Best Interest Rates and Other Tips for Securing Low Mortgage Payments
  • 5 Tips for Making Insurance Work for You
  • Technical Analysis of Stocks

Reviews

  • “Jacob, just wanted to drop you a quick note to thank you for helping me complete my first year of options trading successfully. Although I am still learning what it takes to be a good options trader, I was $11,000 in the black last year (2017)! Thanks for helping me achieve a very prosperous New Year.”

    -John M., Streator, Illinois

Enter Your Log In Credentials

This setting should only be used on your home or work computer.

  • Lost your password? Create New Password
  • No account? Sign up

Need Assistance?

call Cabot Wealth Network Customer Service at

1 (800) 326-8826

  • Manage Account
  • About
  • Contact Us
  • Privacy Policy, Terms of Use, and Premium Service User Agreement
  • Analyst Index
  • Glossary
  • Keyword Index
  • Browse Topics
  • Daily Archive

Copyright © 2022 Cabot Wealth Network
Cabot Heritage Corporation
PO Box 2049
201 Washington Street, Suite 215, Salem, MA 01970 USA
Phone: 1 (800) 326-8826
Email: support@cabotwealth.com

Powered by Mequoda Systems

Subscribe to Our Newsletter

Discover the hottest stocks, investing tips and analysis from Cabot analysts in our free Cabot Wealth Daily newsletter delivered right to your inbox.

Cabot Wealth 50 Plus